AtriCure | ATRC - PE价格收益



金融业
股票价格
USD
资产
USD 654.18M
现金及等价物
USD 167.43M
销售成本
USD 35.16M
流动资产
USD 322.52M
流动负债
USD 81.52M
债务
USD 76.73M
股息收益率
0
EBIT
USD 2.49M
EBITDA
USD 19.86M
员工
1.3K
EPS每股收益
USD 0.06
股本和储备
USD 491.94M
销售毛利
USD 105.34M
债务利息支出
USD 1.33M
利息收入
USD 1.17M
贷款资金
USD 61.87M
市值
USD 1.36B
净收入
USD 1.76M
营业费用
USD 138.01M
营业利润
USD 2.49M
普通股股本
USD 49.7M
PE价格收益
34.15
税前利润
USD 2.36M
销售收入
USD 140.5M
销售和管理费用
USD 78.34M
股票
USD 78.49M
贸易债权人
USD 78.4M
应收帐款人
USD 66.65M


Pe 更改 日
Abbott 24.94 5.78 2026-03
Artivion 212.38 16.51 2025-12
AtriCure 34.15 2.7 2022-06
Baxter International 17.1 4.46 2025-09
Becton, Dickinson and Co. 17.68 114.67 2025-12
Boston Scientific 32.35 5.17 2026-03
Cooper Companies 40.27 15.78 2025-12
Dexcom 32.18 3.28 2025-12
Edwards Lifesciences 26.86 4.76 2026-03
Globus Medical 25.06 6.24 2025-12
Inogen 69.33 30.67 2021-09
Insulet 55.08 5.63 2025-12
Integra LifeSciences 6.58 0.5 2025-12
Intuitive Surgical 55.82 15.79 2026-03
J&J 24.53 0.91 2026-03
Masimo 32.44 71.8 2025-12
Medtronic 22.76 1.32 2025-12
Merit Medical Systems 39.12 6.7 2025-09
ResMed 23.36 4.22 2025-12
Stryker 32.13 2.69 2025-12
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 27.79 16.3 2025-12
Zimmer Biomet Holdings 25.47 7.56 2026-03